Bionexo

Name: Bionexo
Brand: Bionexo

Somos uma empresa de tecnologia SaaS feita para o mercado de saúde.

Est 2000|Valuation $192.9M|Raised $147.8M|25 Ref Customers

LinkedIn 82K|Web traffic 220K|FTEs 922|HQ São Paulo, São Paulo, BR

MarketsSource-to-Pay Source-to-Contract eSourcing

Platform CoversMarketplace Software

01Competitive Landscape

Narrative analysis

- Where the vendor is likely stronger: healthcare-specific procurement workflows and a regional supplier network in Latin America (network effects are a key factor for marketplaces). - Where global suites are stronger: broader procurement functionality, cross-industry supplier ecosystems, and standardized compliance modules supported by large implementation partner networks. - Market trend: recent acquisition activity indicates a strategy to expand beyond procurement into broader hospital operations.

Adoption trends / consolidation signal

Recent reporting indicates the vendor agreed to acquire a hospital management platform, pending regulatory approval. Consolidation can increase platform integration capabilities but also introduces integration risk, product overlap, roadmap uncertainty, and potential changes to commercial terms.

Note: the most relevant competitive dynamics depend on which modules are being evaluated (marketplace, inventory/planning, revenue cycle, analytics).

	Bionexo	SAP Ariba	Coupa
Starting Price	Quote-based (not publicly listed)	Quote-based (enterprise)	Quote-based (enterprise)
Primary use cases	LatAm healthcare providers/suppliers seeking a healthcare-specific network and procurement-to-billing process support	Large enterprises requiring a broad procurement network and mature procurement controls across categories	Enterprises seeking integrated spend management (procure-to-pay, expense, analytics)
Key strengths	Healthcare-focused marketplace and regional supplier network; procurement modalities such as auctions and reverse auctions	Large ecosystem and integrations; mature procurement governance	Broad suite across spend categories and recognized usability in some markets
Key weaknesses	Limited public documentation on security certifications and pricing; fewer public product reviews; potential integration/change-management effort	Can be complex to implement and may be heavy for mid-market hospitals	Typically enterprise-priced; implementation effort can be substantial

01Competitive Landscape

Narrative analysis

Where the vendor is likely stronger: healthcare-specific procurement workflows and a regional supplier network in Latin America (network effects are a key factor for marketplaces).
Where global suites are stronger: broader procurement functionality, cross-industry supplier ecosystems, and standardized compliance modules supported by large implementation partner networks.
Market trend: recent acquisition activity indicates a strategy to expand beyond procurement into broader hospital operations.

Adoption trends / consolidation signal

Note: the most relevant competitive dynamics depend on which modules are being evaluated (marketplace, inventory/planning, revenue cycle, analytics).

	Bionexo	SAP Ariba	Coupa
Starting Price	Quote-based (not publicly listed)	Quote-based (enterprise)	Quote-based (enterprise)
Primary use cases	LatAm healthcare providers/suppliers seeking a healthcare-specific network and procurement-to-billing process support	Large enterprises requiring a broad procurement network and mature procurement controls across categories	Enterprises seeking integrated spend management (procure-to-pay, expense, analytics)
Key strengths	Healthcare-focused marketplace and regional supplier network; procurement modalities such as auctions and reverse auctions	Large ecosystem and integrations; mature procurement governance	Broad suite across spend categories and recognized usability in some markets
Key weaknesses	Limited public documentation on security certifications and pricing; fewer public product reviews; potential integration/change-management effort	Can be complex to implement and may be heavy for mid-market hospitals	Typically enterprise-priced; implementation effort can be substantial